Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | N/A | U8041CA | IM / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | N/A | 3CB9L | IM / RA |
| RAB | RABIES (IMOVAX) | SANOFI PASTEUR | UNK | V1D881M | IM / RA |
| TYP | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) | SANOFI PASTEUR | N/A | V2A451M | IM / RA |
| YF | YELLOW FEVER (YF-VAX) | SANOFI PASTEUR | N/A | UJ830AC | SC / LA |
The patient was administered the one vial prep of Menveo instead of the intended two vial prep. No adverse events were observed or reported following administration upon identification of the variance, the event was documented and the care team was notified.
UNKNOWN
UNKNOWN
UNKNOWN
UNKNOWN
unknown